awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q40672537-328792E9-8026-4475-9CED-22C9B96013DC
Q40672537-328792E9-8026-4475-9CED-22C9B96013DC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40672537-328792E9-8026-4475-9CED-22C9B96013DC
Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?
P2860
Q40672537-328792E9-8026-4475-9CED-22C9B96013DC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40672537-328792E9-8026-4475-9CED-22C9B96013DC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b21b2ea10085333f8a33c4bcf91fa02ab9f7f761
P2860
Phase I immunotoxin trial in patients with B-cell lymphoma.